Mission

Striking the Balance between Innovative and Affordable Medicines

Minapharm has made its mission to provide patients in developing countries with easy access to innovative and high-quality medicines. Minapharm’s expertise encompasses a wide range of medicines, from small molecules with advanced galenic formulation to more complex bioengineered proteins.

Learn More
Science

Driving Innovation in Advanced Life Sciences to Develop Cutting-Edge Technologies, Medicines, and Vaccines

Minapharm develops, manufactures and commercializes over 150 life-saving and life-enhancing products, ranging from small molecules to complex genetically engineered proteins. The company also offers an impressive portfolio of proprietary technologies used by the global biotech industry at large.

smallmol-on-purple smallmol-on-purple
Global Outreach

Crossing International Borders and Scientific Boundaries with Minapharm's Unique Strategic Business Model and Proprietary Technologies

Mianpharm is the only gene-to-market company in Africa and the Middle East providing advanced proprietary technologies to the global biotech industry coupled with end-to-end manufacturing and commercialization expertise for many decades.

...
Subsidiaries
.
Three International subsidiaries headquartered in Cairo and Berlin
...
Manufacturing Sites
.
Six cutting-edge inter-continental manufacturing sites for biological drug substance, biological drug product, and small molecules
...
Business Partnerships
.
Longstanding global and regional business partnerships
Africa & The Middle East

Committed to the Transformation of Healthcare on the African Continent and
the Middle East Region

Minapharm takes a regional approach to affecting global change. Together with its global subsidiary MiGenTra GmbH, Minapharm has a core mission to satisfy the unmet medical needs of patients in Africa and the Middle East.

...
Small Molecules
.
Small Molecules
...
Biosimilars
.
Biosimilars
...
Vaccines
.
Vaccines
...
Cell and Gene Therapies
.
Cell and Gene Therapies
Africa
Making Headlines

Stay Up to Date with the Latest Developments at Minapharm